Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: Role of dimethylarginine dimethylaminohydrolase

Circulation Research

Volumn 92, Issue 2, 2003, Pages 226-233

  Ueda, Seiji ^a   Kato, Seiya ^a,b   Matsuoka, Hidehiro ^a   Kimoto, Masumi ^b   Okuda, Seiya ^a   Morimatsu, Minoru ^a   Imaizumi, Tsutomu ^a  

^a OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Interleukins; Nitric oxide; Nitric oxide synthase; Smooth muscle

Indexed keywords

CYTOKINE; DIMETHYLARGININASE; INTERLEUKIN 1BETA; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; SYNTHESIS; VASCULAR SMOOTH MUSCLE;

AMIDOHYDROLASES; ANIMALS; ARGININE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; INTERLEUKIN-1; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 0037423618     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000052990.68216.EF     Document Type: Article

References (37)

1. Moncada S, Higgs A. The L-arainine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
2. Münzel T, Heitzer D, Harrison DG. The physiology and pathophysiology of the nitric oxide/superoxide system. Herz. 1997;22:158-172.
3. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, Wada Y, Yasukawa H, Iwami G, Okuda S, Imaizumi T. Asymmetrical dimethytarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension. 1997;29:242-247.
4. Böger RH, Bode-Böger SM, Szuba A, Tsao P, Chan J, Tangphao O, Blascke T, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842-1847.
5. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141-1146.
6. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich J. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95: 2068-2074.
7. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res. 1999;43: 542-548.
8. G- dimethylarginine in rats. Arch Biochem Biophys. 1987;252: 526-537.
9. G- dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem. 1989;264:10205-10209.
10. MacAllister RJ, Fickling SA, Whitley GS, Vallance P. Metabolism of methylarginines by human vasculature: implications for the regulation of nitric oxide synthesis. Br J Pharmacol. 1994;112:43-48.
11. G- dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem Tokyo. 1995;117:237-238.
12. G-dimethylarginine dimethytaminohydrolase. Eur J Biochem. 1998; 258:863-868.
13. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999;99:3092-3095.
14. Böger RH, Sydow K, Borak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger S. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res. 2000;87: 99-105.
15. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
16. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20:2032-2037.
17. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell R, Hodson H, Whitley G, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol. 1996;119: 1533-1540.
18. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
19. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32(suppl 3):S62-S66.
20. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 1992; 116:1292-1300.
21. Boota A, Zar H, Kim YM, Johnson B, Pitt B, Davies P. IL-1β stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. Am J Physiol. 1996;271(6 pt 1):L932-L938.
22. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:2153-2157.
23. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997;48:489-509.
24. Hobbs AJ, Higgs A, Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol. 1999;39: 191-220.
25. Wilcox JN, Subramanian RR, Sundell CL, Tracey R, Pollock J, Harrison D, Marsden P. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997; 17:2479-2488.
26. G- dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys. 1993; 300:657-662.
27. Kato S, Yamaguchi M, Fujii T, Miyagi N, Terasaki M, Hamada T, Sugita Y, Morimatsu M. Overexpression of p21Waf-1 in vascular smooth muscle cells: regulation of proliferation, differentiation, and cell size. Exp Mol Pathol. 1999;66:39-52.
28. G- dimethylarginine dimethylaminohydrolase from rat kidney. Biochim Biophys Acta. 1997; 1337:6-10.
29. Leiper JM, Santa-Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Valance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999;343:209-214.
30. Achan V, Tran CTL, Arrigoni F, Whitley GS, Leiper JM, Valance P. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Circ Res. 2002;90:764-769.
31. Buttery L, Springall D, Chester A, Evans T, Stanfield N, Parums D, Yacoub M, Polak J. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
32. Behr D, Rupin A, Fabiani JN, Verbeuren T. Distribution and prevalence of inducible nitric oxide syntbase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis. 1999;142:335-344.
33. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993; 22:34-39.
34. Beasley D, Eldridge M. Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol. 1994;266:R1197-R1203.
35. Geng YJ, Wu Q, Muszynski M, Hansson G, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
36. Ogawa T, Kimoto M, Sasaoka K. Dimethylarginine: pyruvate aminotransferase in rats: purification, properties, and identity with alanineglyoxylate aminotransferase 2. J Biol Chem. 1990;265:20938-20945.
37. Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell. 2001;106:675-683.